Cordant Inc’s Veracyte VCYT Stock Holding History

Cordant Inc’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-63	Closed	-$1.87K	–	109
2025 Q1	$1.87K	Buy	+63	New	+$2.4K	﹤0.01%	88
2022 Q2	–	Sell	-9	Closed	–	–	1206
2022 Q1	$0	Buy	+9	New	+$257	﹤0.01%	1389

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cordant Inc's VCYT Position: Q2 2025 in Review

Cordant Inc sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 63 shares — an estimated $1.87K sold.

Cordant Inc first reported a position in VCYT in Q1 2022 and held it in 2 quarters. The position peaked at $1.87K in Q1 2025. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

Cordant Inc reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
Cordant Inc sold 63 Veracyte shares in Q2 2025, an estimated $1.87K.
Cordant Inc first reported a position in Veracyte in Q1 2022 and held it in 2 quarters.
Cordant Inc's Veracyte position peaked at $1.87K in Q1 2025.
278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Cordant Inc's 13F filing for Q2 2025, filed 15 Jul 2025.